Sangamo Therapeutics News

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

01.03.18	Audentes Therapeutics to Release Fourth Quarter and Full Year 2017 Financial Results and Provide Corporate Update on Thursday, March 8, 2018 (PR Newswire)
28.02.18	Sangamo Announces U.K. Authorization Of Clinical Trial Evaluating Zinc Finger Nuclease In Vivo Genome Editing Treatment For Hemophilia B (PR Newswire)
23.02.18	SGMO Shoots Up On GILD Deal, MESO Has A Blast, Mark Your Calendar For GTHX (RTTNews)
22.02.18	Gilead Unit, Sangamo Therapeutics Enter Worldwide Collaboration (RTTNews)
22.02.18	Kite, a Gilead Company, And Sangamo Therapeutics Announce Collaboration To Develop Next-Generation Engineered Cell Therapies For The Treatment Of Cancer (PR Newswire)
22.02.18	Sangamo Therapeutics Reports Fourth Quarter And Full Year 2017 Financial Results (PR Newswire)
20.02.18	Sangamo Therapeutics Announces Fourth Quarter and Full Year 2017 Conference Call and Webcast (PR Newswire)
13.02.18	Sangamo Presents Oncology Genome Editing Capabilities at Keystone Symposium on Emerging Cellular Therapies (PR Newswire)
12.02.18	Sangamo Therapeutics Announces Appointment Of Heather D. Turner As Senior Vice President And General Counsel (PR Newswire)
08.02.18	TBPH Inks $1Bln Deal, SGMO Hits Yearly High, ANAB Is Back Again (RTTNews)
07.02.18	Case Western Reserve and Sangamo Therapeutics Announce $11 Million NIH Grant for Study of Gene-Edited T Cells for Viral Eradication of HIV (PR Newswire)
07.02.18	GILD's Sales Wane, SGMO Safe With CHAMPIONS, All's Not Well With Veterinarians? (RTTNews)
07.02.18	Sangamo Therapeutics Presents Initial Safety Data from CHAMPIONS Genome Editing Study for MPS II at WORLDSymposium (PR Newswire)
17.01.18	Pareteum Awarded $3 Million Contract to Add Mobility to Established South American Data Network Provider (PR Newswire)
03.01.18	Sangamo, Pfizer Collaborate On Zinc Finger Protein Gene Therapy For ALS (RTTNews)
03.01.18	Sangamo and Pfizer announce collaboration for development of zinc finger protein gene therapy for ALS (PR Newswire)
07.12.17	Sangamo Announces European Medicines Agency Recommendation Of Orphan Medicinal Product Designation For Investigational Genome Editing Treatments For MPS I And MPS II (PR Newswire)
01.12.17	BEAT Upbeat, SYRS Gearing Up For ASH, Catalyst-Rich Year Ahead For ARGX (RTTNews)
17.11.17	Are You Keeping An Eye On EARS And 6 Other Pharma Stocks? (RTTNews)
16.11.17	SGMO Emerges Champion, Mark Your Calendar For ANTH, No Stopping NKTR (RTTNews)
15.11.17	Sangamo Announces Treatment of First Patient in Landmark Phase 1/2 Clinical Trial Evaluating In Vivo Genome Editing for MPS II (PR Newswire)
09.11.17	Sangamo Therapeutics Reports Third Quarter 2017 Financial Results (PR Newswire)
09.11.17	Sangamo Announces Strategic Investment In Manufacturing And Appointment Of Andy Ramelmeier As Head Of Technical Operations (PR Newswire)
09.11.17	Sangamo Announces Plans For New Headquarters In Brisbane, California (PR Newswire)
31.10.17	Sangamo Therapeutics Announces Third Quarter 2017 Conference Call And Webcast (PR Newswire)
25.10.17	Renowned Pain Management Physician Tobias Moeller-Bertram. M.D. to Open 12th Annual Inland Empire Palliative Pain Conference (PR Newswire)
17.10.17	Sangamo Therapeutics Announces Presentations At 2017 Annual Congress Of The European Society Of Gene And Cell Therapy (PR Newswire)
10.10.17	Cambium Networks announces new wireless broadband solutions to extend connectivity (PR Newswire)
02.10.17	Sangamo And Bioverativ Announce FDA Acceptance Of IND Application For ST-400 -- A Gene-Edited Cell Therapy Candidate -- To Treat Beta-Thalassemia (PR Newswire)
28.09.17	Sangamo Therapeutics Announces Participation At Upcoming Investor And Industry Conferences (PR Newswire)
20.09.17	Sangamo Therapeutics Announces Presentation At The 2017 Cantor Fitzgerald Global Healthcare Conference (PR Newswire)
18.09.17	Medizone International announces the appointment of David A. Dodd as new Chief Executive Officer (PR Newswire)
31.08.17	Sangamo Presents T Cell Engineering Capabilities at Immuno-Oncology Summit (PR Newswire)
30.08.17	Sangamo Therapeutics Announces Presentations At Upcoming Investor Conferences (PR Newswire)
30.08.17	ACHV Focuses On Achievement, IMGN Strikes Chord With JAZZ, FDA Snubs ACOR (RTTNews)
25.08.17	Sangamo And Pfizer Announce First Patient Receives Treatment In Phase 1/2 Clinical Trial Evaluating SB-525 Investigational Gene Therapy For Hemophilia A (PR Newswire)
21.08.17	Breakfast Technical Briefing on Biotech Stocks -- Kite Pharma, Novavax, Sangamo Therapeutics, and Spectrum Pharma (PR Newswire)
15.08.17	Gainers & Losers Of Aug.14: TTOO, TBPH, SGMO, APEN, ZYNE... (RTTNews)
11.08.17	Gainers & Losers Of Aug.10: SGMO, VTVT, EDIT, ACRS, CEMP... (RTTNews)
10.08.17	Sangamo Therapeutics Announces Presentation At The 2017 Wedbush PacGrow Healthcare Conference (PR Newswire)
10.08.17	GLPG's FLORA Blooms, DVAX, ESPR Price Offering, SGMO Abuzz, HRTX On Track (RTTNews)
09.08.17	Sangamo Therapeutics Reports Second Quarter 2017 Financial Results (PR Newswire)
02.08.17	Sangamo Therapeutics Announces Second Quarter 2017 Conference Call And Webcast (PR Newswire)
18.07.17	Gainers & Losers Of July 17: ACRX, QDEL, AKCA, SGMO, SUPN... (RTTNews)
14.07.17	Sangamo Therapeutics Holding On To Strong Gain In Afternoon Trading (RTTNews)
14.07.17	FDA Panel Backs 2 Biosimilars, ALDR Abuzz, MDXG Q2 Revenue Grows 33% (RTTNews)
13.07.17	Sangamo Receives Fast Track Designation From The FDA For SB-318 And SB-913 In Vivo Genome Editing Product Candidates For The Treatment Of MPS I And MPS II (PR Newswire)
29.06.17	Sangamo Therapeutics Appoints Roger Jeffs, Ph.D. and Joseph S. Zakrzewski to its Board of Directors (PR Newswire)
26.06.17	Star Tribune Names Perforce a 2017 Top 150 Workplace (PR Newswire)
21.06.17	Sangamo Therapeutics Announces Pricing Of $72.5 Million Public Offering Of Common Stock (PR Newswire)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Alcon	77.62	1.81 %	K V
CieFinRichemont	122.35	0.99 %	K V
Lonza Grp	531.00	0.84 %	K V
Zurich Insur Gr	553.00	0.18 %	K V
Novartis	91.93	0.00 %	K V
ABB	49.54	-0.84 %	K V
Swisscom	504.00	-0.98 %	K V
Sika	228.60	-1.12 %	K V
Holcim	88.42	-1.51 %	K V
UBS Group	27.76	-2.08 %	K V

mehr

26.11.24		Gute Stimmung in New York: Börsianer lassen NASDAQ Composite schlussendlich steigen
26.11.24		Starker Wochentag in New York: NASDAQ Composite präsentiert sich nachmittags fester
26.11.24		Pluszeichen in New York: NASDAQ Composite mittags in Grün
18.11.24		Starker Wochentag in New York: NASDAQ Composite zum Ende des Montagshandels mit Zuschlägen
18.11.24		Optimismus in New York: So steht der NASDAQ Composite aktuell
15.11.24		Schwacher Wochentag in New York: NASDAQ Composite präsentiert sich zum Start leichter
14.11.24		Schwacher Handel in New York: NASDAQ Composite beendet den Handel mit Verlusten
14.11.24		Donnerstagshandel in New York: NASDAQ Composite verbucht nachmittags Verluste

26.11.24

Gute Stimmung in New York: Börsianer lassen NASDAQ Composite schlussendlich steigen

26.11.24

Starker Wochentag in New York: NASDAQ Composite präsentiert sich nachmittags fester

26.11.24

Pluszeichen in New York: NASDAQ Composite mittags in Grün

18.11.24

Starker Wochentag in New York: NASDAQ Composite zum Ende des Montagshandels mit Zuschlägen

18.11.24

Optimismus in New York: So steht der NASDAQ Composite aktuell

15.11.24

Schwacher Wochentag in New York: NASDAQ Composite präsentiert sich zum Start leichter